Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fasting State

An Open Label, Randomized, Single Dose, Crossover Study to Evaluate the Pharmacokinetics and Safety of DA-5210 10/500mg in Healthy Subjects at Fasting State

Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy subjects at Fasting State

Inclusion Criteria:

• Healthy Volunteers
• BMI between 18 and 30 kg/m2
• Body weight : Male≥50kg, Female≥45kg

Exclusion Criteria:

• Allergy or Drug hypersensitivity
• Clinically significant Medical History